
Biocon Limited
Biocon Limited is a significant name in the Indian medicine market for its procurement of biosimilar items for insulin, oncology drugs, and immunology drugs. The biosimilar drug to insulin is Insugen. CanMAb and AlzuMAb are two major brands that are manufactured and marketed by the company. The company has a global market all over in Europe.
Showing 1–8 of 9 results

